11:58 AM EST, 02/12/2025 (MT Newswires) -- Kala Bio ( KALA ) said Wednesday that Mark Iwicki has resigned as chief executive, effective immediately, but will continue to serve as board chair.

The clinical-stage biopharmaceutical company appointed President and Chief Operating Officer Todd Bazemore as interim CEO.

Kala Bio ( KALA ) shares were down about 34% in recent trading.

Price: 7.11, Change: -3.77, Percent Change: -34.65